ASSESSING TESTOSTERONE LEVELS IN MEN WITH TYPE 2 DIABETES: A CROSS-SECTIONAL STUDY IN PRIMARY CARE
DOI:
https://doi.org/10.25110/arqsaude.v29i2.2025-11750Palavras-chave:
Cardiovascular Risk Factors, Hypogonadism, Testosterone, Type 2 Diabetes MellitusResumo
Objective: This study aimed to assess the prevalence of hypogonadism and its risk factors in Brazilian men with Diabetes Mellitus type 2, as well as testing the accuracy of laboratory diagnosis against The Androgen Deficiency in Aging Males (ADAM) questionnaire for the initial screening of testosterone deficiency. Methodology: A cross-sectional study was conducted with 38 type 2 diabetic men between January and May 2023 at the primary care using plasma testosterone levels for hypogonadism detection and the ADAM questionnaire comparatively. Statistical analyses were performed for normality, correlation, and association. All participants signed a free and informed consent form approved by the Ethics Committee. Results: The research identified a prevalence of hypogonadism of 47.1% among the participants. Factors such as advanced age, BMI >30.0 kg/m2, increased abdominal circumference, and high total cholesterol were associated with hypogonadism in type 2 diabetics. The ADAM questionnaire had modest accuracy (41.2%) (despite the participants' reliable response pattern (Cronbach`s alpha = 0.72). Conclusion: Hypogonadism is common in type 2 diabetics and was prevalent in almost half of the participants being associated to cardiovascular risk factors. The ADAM questionnaire had a poor performance in detecting hypogonadism in this group.
Downloads
Referências
ABDELMAGEED, R. M.; MOHAMMED HUSSEIN, S. M. Risk of Depression and Suicide in Diabetic Patients. Cureus, v. 14, n. 1, 2022. DOI: https://doi.org/10.7759/cureus.20860
AL HAYEK, A. A. et al. Prevalence of low testosterone levels in men with type 2 diabetes mellitus: a cross-sectional study. Journal of Family and Community Medicine, v. 20, n. 3, p. 179, 2013. DOI: https://doi.org/10.4103/2230-8229.122006
AMERICAN DIABETES ASSOCIATION. Standards of Medical Care in Diabetes—2020 Abridged for Primary Care Providers. Clin Diabetes, v. 38, n. 1, p. 10-38, 2020. DOI: https://doi.org/10.2337/cd20-as01
ANDLIB, N. et al. Abnormalities in sex hormones and sexual dysfunction in males with diabetes mellitus: A mechanistic insight. Acta Histochemica, v. 125, n. 1, p. 151974, 2023. DOI: https://doi.org/10.1016/j.acthis.2022.151974
ASHGHALI-FARAHANI, M. et al. Androgen deficiency in elderly men: a study of translation and validation of the Iranian version. Iran J Nurs Midwifery Res, v. 26, n. 2, p. 144-149, 2021. DOI: https://doi.org/10.4103/ijnmr.IJNMR_209_20
ÇATAKOGLU, A. B.; KENDIRCI, M. Testosterone replacement therapy and cardiovascular events. Turk Kardiyol Dern Ars, v. 45, n. 7, p. 664-672, 2017. DOI: https://doi.org/10.5543/tkda.2017.00531
CHU, L. W. et al. A brief version of the ADAM questionnaire for androgen deficiency in Chinese men. The Journals of Gerontology: Series A, v. 63, n. 4, p. 426-431, 2008. DOI: https://doi.org/10.1093/gerona/63.4.426
CLARK, N. G.; FOX, K. M.; GRANDY, S.; for the SHIELD Study Group. Symptoms of diabetes and their association with the risk and presence of diabetes. Diabetes Care, v. 30, n. 11, p. 2868-2873, 2007. DOI: https://doi.org/10.2337/dc07-0816
CORONA, G. et al. Testosterone therapy in diabetes and pre-diabetes. Andrologia, v. 11, n. 2, p. 204-214, 2023. DOI: https://doi.org/10.1111/andr.13367
EBRAHIMI, F.; CHRIST-CRAIN, M. Metabolic syndrome and hypogonadism--two peas in a pod. Swiss Med Wkly, v. 146, n. 14283, 2016. DOI: https://doi.org/10.4414/smw.2016.14283
EJIOFOR, T. U.; ROSEMARY, T. I. Androgen deficiency in aging males Questionnaire for the clinical detection of testosterone deficiency in a sub-Saharan African black male population with type 2 diabetes mellitus: is it a reliable tool? Curr Diabetes Rev, v. 14, n. 3, p. 280-285, 2018. DOI: https://doi.org/10.2174/1573399812666161228152036
FALLARA, G. et al. Cardiovascular morbidity and mortality in men – results of a meta-analysis on the time-related risk measure of exogenous testosterone. The Journal of Sexual Medicine, v. 19, n. 8, p. 1243-1254, 2022. DOI: https://doi.org/10.1016/j.jsxm.2022.05.145
FAROOQI, A. et al. A systematic review and meta-analysis to compare the prevalence of depression between people with and without type 1 and type 2 diabetes. Primary Care Diabetes, v. 16, n. 1, p. 1-10, 2022. DOI: https://doi.org/10.1016/j.pcd.2021.11.001
GROSSMANN, M.; TANG FUI, M.; CHEUNG, A. S. Late-onset hypogonadism: metabolic impact. Andrologia, v. 8, n. 6, p. 1519-1529, 2020. DOI: https://doi.org/10.1111/andr.12705
GRUNDY, S. M. et al. 2018 AHA / ACC / AACVPR / AAPA / ABC / ACPM / ADA / AGS / APhA / ASPC / NLA / PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation, v. 139, n. 25, p. 1082-1143, 2019. DOI: https://doi.org/10.1161/CIR.0000000000000698
HOLICK, M. F. et al. Evaluation, Treatment, and Prevention of Vitamin D Deficiency: An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology & Metabolism, v. 96, n. 7, p. 1911-1930, 2011. DOI: https://doi.org/10.1210/jc.2011-0385
HSU, P.-S.; et al. Waist circumference is more closely associated with hypogonadism than hyperglycemia, independent of BMI in middle-aged men. Journal of Diabetes Research, 2021. DOI: https://doi.org/10.1155/2021/1347588
IRANPARVAR, M.; AMAMI, F.; NAGHIZADEH, M. J. Serum testosterone levels and clinical signs of hypogonadism in men with type 2 diabetes. International Journal of Community Medicine and Public Health, v. 8, n. 8, p. 3777-3781, 2021. DOI: https://doi.org/10.18203/2394-6040.ijcmph20213002
JIN, M. Association between prediabetes and erectile dysfunction: a meta-analysis. Frontiers in Endocrinology, v. 12, 2022. DOI: https://doi.org/10.3389/fendo.2021.733434
LISCO, G. et al. Age-Related Male Hypogonadism and Cognitive Impairment in the Elderly: Focus on the Effects of Testosterone Replacement Therapy on Cognition. Geriatrics (Basel), v. 5, n. 4, p. 76, 2020. DOI: https://doi.org/10.3390/geriatrics5040076
MAJUMDAR, S. et al. Testosterone replacement therapy in men with type 2 diabetes mellitus and functional hypogonadism –an Integrated Diabetes and Endocrine Academy (IDEA) consensus guideline. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, v. 15, n. 4, p. 102191, 2021. DOI: https://doi.org/10.1016/j.dsx.2021.102191
MORLEY, J. E. et al. Validation of a screening questionnaire for androgen deficiency in aging men. Metabolism, v. 49, n. 9, p. 1239-1242, 2000. DOI: https://doi.org/10.1053/meta.2000.8625
MUZY, J. et al. Prevalência de diabetes mellitus e suas complicações e caracterização das lacunas na atenção à saúde a partir da triangulação de pesquisas. Cadernos de Saúde Pública, v. 37, n. 5, 2021. DOI: https://doi.org/10.1590/0102-311x00076120
ONG, K. L. et al. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet, v. 402, n. 10397, p. 203-234, 2023.
PARK, H. J.; AHN, S. T.; MOON, D. G. Evolution of guidelines for testosterone replacement therapy. J Clin Med, v. 8, n. 3, p. 410, 2019. DOI: https://doi.org/10.3390/jcm8030410
PERALTA ANDRADE, K. A.; PALACIO ROJAS, M. A. Abdominal circumference cutoff point: an overview. [S. l.]: [s. n.], v. 41, n. 3, p. 299-306, 2022.
RABAH, D. M.; ARAFA, M. A. Validation of an Arabic ADAM questionnaire for screening of androgen deficiency in the Arab community. The Aging Male, v. 12, n. 4, p. 95-99, 2009. DOI: https://doi.org/10.3109/13685530903265065
SINGH, J. et al. Assessment of hypogonadism and its determinants among adult men with type 2 diabetes mellitus. Primary Care Diabetes, v. 17, n. 4, p. 348-353, 2023. DOI: https://doi.org/10.1016/j.pcd.2023.05.005
THEODORAKIS, N. et al. Testosterone therapy for functional hypogonadism in middle-aged and elderly men: current evidence and future perspectives. Hormones, v. 23, p. 801–817, 2024. DOI: https://doi.org/10.1007/s42000-024-00587-2
WEIR, C. B.; JAN, A. BMI classification percentile and cut-off points. StatPearls Publishing, Treasure Island, P. 1-5, 2023.
ZHANG, J. et al. Effects of testosterone supplementation treatment in adult hypogonadal men with T2DM: a meta-analysis and systematic review. World J Urol, v. 36, n. 8, p. 1315-1326, 2018. DOI: https://doi.org/10.1007/s00345-018-2256-0
Downloads
Publicado
Como Citar
Edição
Seção
Licença
Copyright (c) 2025 Arquivos de Ciências da Saúde da UNIPAR
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
Os Direitos Autorais para artigos publicados são de direito da revista. Em virtude da aparecerem nesta revista de acesso público, os artigos são de uso gratuito, com Creative Commons Attribution 4.0 International License.
A revista se reserva o direito de efetuar, nos originais, alterações de ordem normativa, ortográfica e gramatical, com vistas a manter o padrão culto da língua e a credibilidade do veículo. Respeitará, no entanto, o estilo de escrever dos autores.
Alterações, correções ou sugestões de ordem conceitual serão encaminhadas aos autores, quando necessário. Nesses casos, os artigos, depois de adequados, deverão ser submetidos a nova apreciação.
As opiniões emitidas pelos autores dos artigos são de sua exclusiva responsabilidade.
